Skip to main content
Equibles

Serge Belanche

Analyst

Needham

Equibles does not estimate personal net worth.

About Serge Belanche

Serge Belanche is recorded as Analyst at Needham. Serge Belanche has spoken on 1 earnings call across 1 company, most recently for Cytokinetics Inc on November 4, 2026. The companies whose calls Serge Belanche spoke on are classified in the Healthcare sector.

Serge Belanche on recent calls

“I may have missed this in your prepared comments, but just the level of switching that you saw this quarter from Camzaios to Macorzo, you know, whether it was stable and whether it's behind the downtick that they reported in Camzaios sales in the third quarter in the U.S. last week.”
Analyst — Needham, Cytokinetics Q3 2026 Earnings Conference Call ·

Affiliation history

  • Needham

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity